Scott Wallask, BA

Scott Wallask, BA, is senior editorial manager for Today’s Clinical Lab and G2 Intelligence. He has spent more than 25 years covering the healthcare and high-tech industries. A former newspaper reporter, he graduated from Northeastern University with a degree in journalism.

Home
Author
Scott Wallask, BA

Articles by Scott Wallask, BA

Image of the US White House. Clinical labs are wondering how incoming President Donald Trump might influence LDT changes.

Will President-Elect Donald Trump Change the FDA’s LDT Final Rule?

Scott Wallask, BA

Clinical labs eager for relief from upcoming FDA compliance dates are looking to the new presidential administration

: Image of Congress with a backdrop of a hundred-dollar bill. PAMA cuts to clinical lab services were avoided by a recent vote in Congress.

PAMA Cuts Averted Again for Clinical Lab Services

Scott Wallask, BA

ACLA applauds congressional action to delay Medicare decreases and urges long-term reform

Image of Tosoh Bioscience’s G8 analyzer, one option for medical labs in the clinical chemistry analyzer market.

Clinical Chemistry Analyzer Market on the Rise: What’s Driving Demand?

Scott Wallask, BA

To capture new demand, clinical labs should note advancing technology and rising disease mortality

Photo taken of the front of the U.S. Supreme Court showing stairs and large columns.

Future of FDA’s LDT Rule Uncertain with Latest Supreme Court Decision

Scott Wallask, BA

In overturning the Chevron case, justices diminish the power of federal agencies like the FDA

Judge’s gavel on legal reference books

ACLA Sues the FDA Over Final Rule to Regulate Laboratory-Developed Tests as Medical Devices

Scott Wallask, BA

‘FDA’s final rule is the wrong approach’ for LDTs, ACLA president says

Participants at conference raise arms upward

Tips to Improve Lab Advocacy and Employee Engagement

Scott Wallask, BA

These two goals were prominent themes during the Lab Manager Leadership Summit’s Clinical Track

Sign outside FDA headquarters

ADLM President: 'LDTs Should Remain under CLIA'

Scott Wallask, BA

Octavia Peck Palmer reacts to the FDA’s new final rule on lab-developed tests

Illustration concept of someone holding a magnet that is pulling small lightbulbs out of a human brain against a blue background.

There’s a ‘Brain Drain’ in the Cancer Research Industry

Scott Wallask, BA

Clinical lab leaders will recognize the plight of cancer investigators leaving the field

An automated liquid handling system picks microtips from tip boxes to aspirate a reaction component.

Trust in Clinical Lab Automation Takes a New Turn

Scott Wallask, BA

It’s unclear whether younger laboratory professionals will harness the full potential of automation

A clinical pathologist at a hub laboratory examines a sample using a microscope.

New Digital Pathology Network Aims to Benefit Smaller Clinical Labs

Scott Wallask, BA

Nuance and Paige say their new consultation network will also generate revenue for larger laboratories

Photo of three clinical laboratory professionals wearing PPE standing in front of a glass window with green leaves in the background.

When Recruiting Gen Z Talent, Clinical Labs Should Consider Green Initiatives

Scott Wallask, BA

New report on carbon emissions examines issue that resonates with many younger workers